India-Based Spinchrom Life Sciences to Market Innovative BLItz Platform from Pall Corporation (PLL)'s ForteBio Division
4/17/2013 11:16:50 AM
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced that Pall India Pvt. Ltd. has entered into an exclusive India distribution agreement with a leading biosupplier, Spinchrom Life Sciences, a division of Spinco Biotech Pvt. Ltd. Through the agreement, Spinchrom will become the exclusive distributor to market in India ForteBio’s BLItz system, a revolutionary platform that uniquely enables scientists to conduct label-free analyses of proteins using small sample volumes easily and cost-efficiently at their laboratory bench. ForteBio is a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products.
comments powered by